baber/WOPTO huggingface dataset:
Patent JP-2926990-B2 (JP)
IPC: C12N9/10
Filed: 1994-11-28
Granted: 1999-07-28
Abstract: A bacterium belonging to the genus  Escherichia,  which is transformed by introducing, into its cells, a DNA coding for a dihydrodipicolinate synthase originating from a bacterium belonging to the genus  Escherichia  having mutation to desensitize feedback inhibition by L-lysine and a DNA coding for an aspartokinase III originating.from a bacterium belonging to the genus  Escherichia  having mutation to desensitize feedback inhibition by L-lysine; preferably a bacterium belonging to the genus  Escherichia  in which a dihydrodipicolinate reductase gene and a diaminopimelate dehydrogenase gene originating from  Brevibacterium lactofermentum  (or a succinyldiaminopimelate transaminase gene and a succinyldiaminopimelate deacylase gene) are further enhanced, is cultivated in an appropriate medium, L-lysine is produced and accumulated in a culture thereof, and L-lysine is collected from the culture.
Patent JP-4351298-B2 (JP)
IPC: C07D401/04
Filed: 1997-10-02
Granted: 2009-10-28
Abstract: 1-(Benzyl or heterocyclylmethyl)-3-(substituted (hetero)aromatic)-fused pyrazole compounds of formula (I) are new. X = O, S NH or CH=CH, and the X-containing ring is optionally substituted by R14; R1 = phenyl, 2-thienyl, 2-pyrrolyl or 2-furanyl, all substituted by R4; R4 = CHOHCH3, 2-6C alkyl (substituted by OH or 1-4C alkoxy), CHO, 1-6C acyl, NO2, 1-6C alkyl (optionally substituted by NH2, N3 or OR5), CH2OR13, or a group of formula (a) or (b); A = phenyl (optionally mono-, di- or trisubstituted by alkyl, alkoxy, alkoxycarbonyl, (each with up to 6C), COOH, NO2, CN, CF3, N3 or halo; R5 = 1-5C acyl, SiR6R7R8, CH2OR10 or a group of formula (c); R6-R8 = 6-10C aryl, 1-6C alkyl; R9, R13 = H or 1-3C alkyl; R10-R12 = H or 1-4C alkyl; R14 = OH, halo, 1-4C alkoxy or 1-4C alkyl; a = 1-3: provided that when R4 = CH2OR13, then A = substituted phenyl where the substituents include alkoxycarbonyl, COOH, NO2, CN, CF3 or N3.
Patent JP-3549207-B2 (JP)
IPC: A61K45/08
Filed: 1995-12-18
Granted: 2004-08-04
Abstract: A pharmaceutical product for the release of medicinal agents to the skin having absorption-increasing auxiliary agents is characterized in that the auxiliary material forms subcooled melts.
Patent JP-3027769-B2 (JP)
IPC: G01B11/14
Filed: 1994-04-15
Granted: 2000-04-04
Abstract: A device for accurately measuring flying heights of a read/write head in a disk drive down to zero microinches using interferometry, wherein the flying height of the head above the disk surface is calculated by directing white light to the under side of a rotating disk. An interference pattern is obtained by reflecting a first portion of the light off of the top surface of the disk and reflecting a second portion of the light off of the underside of the read/write head, and then recombining the first and second portions of light. The interference pattern is then input to a spectrophotometer, which creates an intensity profile from which the flying height of the read/write head above the disk may be calculated. A spacer layer is provided on the upper surface of the disk to increase the phase difference of the first and second portions of light, thereby allowing clear interpretation of the interference pattern at extremely low flying heights.
Patent JP-3635093-B2 (JP)
IPC: A61B17/06
Filed: 1995-02-16
Granted: 2005-03-30
Abstract: A device and method of suturing closed an opening and ligating a vessel or duct comprising removable tissue puncturing means (22) or vessel surrounding means establishing a continuous channel (24) through said tissue or around said vessel from each side. A completed channel (24) is formed and suture material (26) is threaded through the channel making a complete loop. The thread is secured at an anvil (30) independent from said puncturing/surrounding means. The puncturing/surrounding means is retracted leaving the thread, which is then tensioned closing the opening or occluding the vessel. The suture thread is secured and cut, forming a closed loop with overlapping ends. An energy transmitting device (38) melts the suture thread ends together forming a weld. The anvil (30) is removed leaving a knot-free completed stitch or ligature.
Patent JP-3749734-B2 (JP)
IPC: F16G13/06
Filed: 1997-12-10
Granted: 2006-03-01
Abstract: A drive chain has opposed pairs of inner link plated that are interconnected by cast outer links. Pins pass through aligned apertures in overlapping end portions of the inner and outer links. Each pin is fixed relative to the inner link. The outer link has open or blind bores that receive end portions of the pins in a pivotal relationship. A bearing area is defined between the outer surface of the pin and an inner surface of the outer link bore. The provision of a bearing area in the outer link makes maintenance and sealing easier.
Patent JP-3697266-B2 (JP)
IPC: G11C5/00
Filed: 1997-04-16
Granted: 2005-09-21
Abstract: The present invention reduces the area on a die required for rows and columns of redundant memory cells by sharing compare circuitry with banks of redundant memory cells based on division of the primary memory array into two or more "planes." Pass gates or multiplexers coupled between at least two banks of fuses and one compare circuit selectively couple the appropriate fuse bank to the compare circuit. Preferably, a bit in the address (e.g., address bit RA 9 in a row address word having address bits A 0 -RA 9 ) is received by and controls the multiplexer to select between the two banks of fuses. Additionally, the planes span blocks of memory in the memory array, where each block is divided by shared sense amplifiers. As a result, while eight lines are coupled to 16 rows or columns, only eight rows or columns will be active at any one time because isolation gates will enable only eight of the 16 rows or columns within two planes of memory. As a result, the present invention saves on the number of lines required to intercouple the compare circuits to the redundant rows/columns.
Patent JP-4129296-B2 (JP)
IPC: A61B17/11
Filed: 1998-04-14
Granted: 2008-08-06
Abstract: A medical fluid suctioning device for selectively applying varied levels of suction pressure at a device-tissue interface includes a direct "trumpet"-type control mechanism in conjunction with a "venturi"-type control. A valve manifold is adapted to couple a vent pathway and a suction pathway simultaneously to the vacuum conduit adapted for connection to a vacuum source. The amount of resistance to flow due to vacuum pressure is adjusted simultaneously in both the vent pathway and the suction pathway in order to achieve controlled, selected levels of suction. Similarly shaped valve apertures are provided in inverse and reciprocal orientation along an axis of motion of a valve manifold. The apertures translate across ports to the suction and venting pathways simultaneously to vary applied suction to those pathways inversely. The shaped valve apertures preferably have diminished elliptical shapes having an elongate axis with an increasing cross-sectional area going from a transverse short axis to a transverse wide axis along the axis of motion of the valve manifold. The diminished elliptical shapes are inversely oriented relative to each other as regards the positioning of their wide and short transverse axis along the axis of motion.
Patent JP-4463882-B2 (JP)
IPC: C03C27/12
Filed: 1998-03-19
Granted: 2010-05-19
Abstract: The present document describes a process for manufacturing a pane of laminated glass without recourse to an autoclave. The pack of layers are composed of stacked layers (6, 7, 8), is raised to the softening temperature of the thermoplastic interlayer of the pack of layers in a preheat channel (1). The preheated pack of layers is put under vacuum in a vacuum assembly station (2) for the purpose of extracting the gas from the spaces separating the layers (6, 7, 8). After the gas has been extracted, the edge of the pack of layers, which is heid under vacuum, is mechanically compressed inside the vacuum box and is thus sealed. Finally, the pack of layers is brought to atmospheric pressure and its temperature further increased in a postheat channel (4).
Patent ES-2237346-B2 (ES)
Title: Mecanismo de encaminamiento tolerante a fallos altamente escalable.
Inventor: PUENTE VARONA VALENTIN
IPC: H04L12/56
Filed: 2005-03-01
Granted: 2006-07-16
Abstract: Mecanismo de encaminamiento tolerante a fallos altamente escalable denominado S-Immunet, que se caracteriza por ser un mecanismo eficiente para tolerar fallos en redes de interconexión de computadores paralelos y distribuidos. El mecanismo está basado, por un lado, en un método de reencaminar los mensajes cuando se produce un fallo en la red y por otro lado, en una estructura hardware específica del aparato encaminador de mensajes. Las principales diferencias con los mecanismos previos de tolerancia a fallos son que la invención puede ser aplicada a redes muy grandes (miles de nodos) de tipo k-ary n-cube; no produce una sobrecarga de la red en ausencia de fallo; reconfiguración automática y transparente a la aplicación; reparados los componentes se recupera el rendimiento de la red antes del fallo y el nuevo mecanismo además es capaz de tolerar cualquier número de fallos de enlace y cualquier combinación espacial y temporal de fallos.
Patent ES-2328998-B2 (ES)
Title: Metodo de reduccion del tiempo de descarga de paginas web.
Inventor: DOMENECH DE SORIA JOSEP
IPC: G06F17/30
Filed: 2007-12-05
Granted: 2010-04-21
Abstract: Método de reducción del tiempo de descarga de
páginas Web. 
     La invención se refiere a un método de reducción
del tiempo de descarga  de una página de un servidor Web, en el
que: 
     - el servidor obtiene un identificador de
frescura de un objeto asociado  a una URL de una relación de URLs
dada; caracterizado porque: 
     - el servidor pone a disposición de un cliente
dicha relación de URLs y  los identificadores de frescura (300, 400,
500) de dichos objetos asociados  a las URLs antes de que el cliente
solicite el objeto correspondiente; 
     y porque: 
     - el cliente utiliza dichos identificadores de
frescura, una vez los reciba  del servidor, para actualizar una
marca de tiempo de un objeto que se encuentra  en una caché del
cliente y cuyo objeto tiene asociado una URL para la cual  el
servidor ha proporcionado el identificador de frescura.
Patent ES-2351125-B2 (ES)
Title: Equipo y procedimiento para la medición de la velocidad de consumo de oxígeno de fangos activados para una concentración de sustrato orgánico biodegradable determinada.
Inventor: FERRER POLO JOSE
IPC: C02F3/12
Filed: 2008-01-09
Granted: 2012-01-27
Abstract: Equipo y procedimiento para la medición de la velocidad de consumo de oxígeno de fangos activados para una concentración de sustrato orgánico biodegradable determinada.#El equipo de la invención comprende un reactor (1), un agitador (2), medios para medir la concentración de oxígeno (3), un depósito (4) de fangos activados, medios de dosificación (5) de un sustrato orgánico biodegradable, y una bomba (6) para llenar y vaciar el reactor (1). Dichos medios de dosificación (5) comprenden un cilindro con un émbolo (17), estando accionado por un motor (15) a través de un eje. Adicionalmente un dispositivo controlador (16) controla el desplazamiento del émbolo en el cilindro. Dicho equipo puede ser empleado para determinar la velocidad de consumo de oxígeno de fangos activados para distintas concentraciones de sustrato orgánico biodegradable determinadas, llevando a cabo las etapas de carga de un fango activado en un reactor (1), homogeneización de dicho fango activado, medición del consumo de oxígeno en fase endógena, inyección de una cantidad predeterminada de sustrato, y medición del consumo de oxígeno en fase exógena.
Patent ES-2575752-B2 (ES)
Title: Obtención de extractos liquénicos y uso de los mismos para mejorar la recuperación de microorganismos asociados a líquenes
Inventor: GONZALEZ BIOSCA ELENA
IPC: C12N1/00
Filed: 2014-12-31
Granted: 2017-01-17
Abstract: Obtención de extractos liquénicos y uso de los mismos para mejorar la recuperación de microorganismos asociados a líquenes.#La presente invención se refiere un extracto liquénico y el uso del mismo para mejorar la recuperación de microorganismos asociados a líquenes. Así, la invención va dirigida a un método para mejorar u optimizar el aislamiento y/o cultivo de microorganismos asociados a líquenes que comprende el procesado de talos liquénicos lavados o lavados y machacados en un medio de cultivo que comprende el extracto liquénico de una población de la especie de liquen de la que se quieren aislar los microorganismos. También se describen el método de obtención del extracto liquénico y la composición que comprende el extracto liquénico así obtenido.
Patent AU-2000242215-B2 (AU)
Title: Intra-aortic balloon catheter having an ultra-thin stretch blow molded balloon membrane
Inventor: LAKSIN OLGA
IPC: A61M60/843
Filed: 2000-04-07
Granted: 2004-12-23
Abstract: An intra-aortic balloon catheter (30) having an ultra-thin stretch blow molded balloon membrane (36). The balloon membrane (36). he balloon membrane is made from thermoplastic elastomeric and/or semicrystalline materials such as but not limited to polyurethane and polyetheramid.
Patent AU-2001272464-B2 (AU)
Title: Stabilisation of light sensitive substances
Inventor: KULLAR JATINDER SINGH
IPC: C09K23/52
Filed: 2001-06-12
Granted: 2006-08-10
Abstract: An emulsion comprising an organic discontinuous phase which is distributed throughout a continuous aqueous phase, wherein the organic phase comprises a light sensitive active ingredient, and the emulsion is stabilised by a water soluble stabilising material in the aqueous phase, wherein the water-soluble stabilising material is a water-soluble stabilising polymer which has a plurality of hydrophilic and hydrophobic groups and is selected from partially hydrolysed polyvinyl acetate and addition copolymers formed from (i) at least one ethylenically unsaturated carboxylic acid esters and (ii) at least one ethylenically unsaturated carboxylic acid or ethylenically unsaturated carboxylic acid anhydride, and wherein the organic phase further comprises, a) an organic solvent which is a liquid at 25° C. and/or b) an organic phase stabilising material comprises hydrophobic moieties and is a material which is more soluble in the organic phase than the aqueous phase. The composition is useful for protecting light sensitive active ingredients which would otherwise in neat form decompose on exposure to light, preferably sunlight. The invention is of particular value when the light sensitive active ingredient is a pesticide, herbicide or a veterinary treatment active. Preferably the light sensitive active ingredient is a light sensitive pyrethroids. The invention also contemplates a domestic pest control formulation comprising light sensitive pesticides.
Patent AU-2001278073-B2 (AU)
Title: Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
Inventor: HORUK RICHARD
IPC: A61K45/06
Filed: 2001-07-31
Granted: 2005-06-30
Abstract: This invention is directed to pharmaceutical compositions useful in treating heart transplant rejection in mammals comprising a pharmaceutically acceptable excipient, a therapeutically effective amount of a non-peptide CCR1 receptor antagonist and a sub-nephrotoxic amount of cyclosporin A.
Patent AU-2001291755-B2 (AU)
Title: Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
Inventor: THOMPSON LAWRENCE H
IPC: A61K33/24
Filed: 2001-08-09
Granted: 2006-05-18
Abstract: The invention discloses several novel therapeutic properties and methods of treatment using the recombinant erythropoietin prepared by expression from the Apa I restriction fragment of human genomic erythropoietin DNA transformed into baby hamster kidney cells (BHK) according to U.S. Patent No. 5,688,697 to Powell. This recombinant erythropoietin designated herein as Epoetin Omega is shown to possess several unexpected and superior qualities over other recombinant erythropoieteins such as those designated Epoetin Alfa and Beta which are prepared from genomic or cDNA expressed in Chinese Hamster Ovary (CHO) according to U.S. Patent Nos. 4,703,008 and 5,955,422 to Lin. The superior properties of Epoetin Omega include, but are not limited to, a much higher potency, a much more rapid response (i.e. no latency), longer effective serum levels, much lower antigenicity in human subjects, therapeutic activity in subjects non-responsive to the other epoetins, fewer adverse side effects such as incidents of thrombosis, reduced nausea, reduced pain at the site of injection, reduction in body pain, and most significantly, the absence of, or reduced risk of, increased blood pressure or hypertension. These novel properties provide for novel therapeutic methods including, treatment of anemia and treatment of conditions other than anemia such as fatigue or vascular pain, treatment in patients adversely effected by hypertension such as patients with heart conditions or at increased risk of thrombosis, treatment in oncology settings with and without chemotherapy or radiation therapy, and treatment with novel dosing regiments that include much lower doses and lower administration frequencies of as few as once per week or less.
Patent AU-2001294234-B2 (AU)
Inventor: OKAMOTO RYOICHI
IPC: C02F1/66
Filed: 2001-10-12
Granted: 2003-04-28
Abstract: To purify wastewater discharged from lavatories (3), a wastewater purifying apparatus having a shell contact aeration chamber (6, 7) placed with shell microbial carrier members (15), the wastewater being fed to and purified in the shell contact aeration chamber (6, 7). Shells whose mother-of-pearl layer on the inner surface (b) is at least removed are used as the microbial carrier member (15). <IMAGE>
Patent AU-2002222963-B2 (AU)
Title: Performing spreadsheet-like calculations in a database system
Inventor: DORMAN GREGORY
IPC: G06F12/00
Filed: 2001-06-20
Granted: 2007-05-10
Abstract: A method and system for performing spreadsheet-like operations in a database system is described herein. As explained, a database language is extended to introduce new clauses ("spreadsheet-like clauses"), for defining and executing spreadsheet-like operations on data contained within a RDBMS. According to one aspect of the invention, in response to receiving a database query that specifies an operation for manipulating data, data from a relational structure is retrieved and stored in a non-relational structure that can be addressed as a multi-dimensional array. The operation specified in the database query is the performed on then data.
Patent AU-2002236676-B2 (AU)
Title: Microcoil vaso-occlusive device with multi-axis secondary configuration
Inventor: FERRARA DAVID A
IPC: A61B17/12
Filed: 2001-11-07
Granted: 2008-02-28
Abstract: A vaso-occlusive device (10) includes a microcoil (12) formed into a minimum energy state secondary configuration comprising a plurality of curved segments (14a,14b,24), each defining a discrete axis (16), whereby the device, in its minimum energy state configuration, defines multiple axes. In a preferred embodiment, the minimum energy state secondary configuration comprises a plurality of tangentially-interconnected, substantially circular loops (14a,14b) defining a plurality of discrete axes (16). In an alternative embodiment, the minimum energy state secondary configuration defines a wave-form like structure comprising a longitudinal array of laterally-alternating open loops (24) defining a plurality of separate axes (16). In either embodiment, the device (10), in its minimum energy state secondary configuration, has a dimension that is substantially larger than the largest dimension of the vascular site in which the device is to be deployed. Thus, when the device (10) is deployed in an aneurysm (40) , the confinement of the device (10) within the aneurysm (40) causes the device (10) to assume a three-dimensional configuration that has a higher energy state than the minimum energy state.
Patent AU-2002237404-B2 (AU)
Title: Vehicular linear pneumatic propulsion system
Inventor: TIDMARSH THOMAS JOHN SCOTT
IPC: B61B13/00
Filed: 2002-03-01
Granted: 2005-07-07
Abstract: A vehicular linear propulsion system for use along a track, comprising: a tubular drive line ( 3 ) divided lengthwise into a plurality of mutually-sealed sectors connected end-to-end by sector gate air valves (SG); at least one main supply pipe running adjacent, preferably parallel, to the drive line for the supply of air to the drive line or the evacuation of air from the drive line; at least two main air valves (V 1 , V 2 or P 1 , P 2 ) near respective ends of each sector for selective communication with the main supply pipe; and two exhaust air valves (I 1 , I 2 or E 1 , E 2 ) near respective ends of each sector for selective communication with the atmosphere for exhausting air or taking air in.
Patent AU-2002310015-B2 (AU)
Title: Delivery of antipsychotics through an inhalation route
Inventor: RABINOWITZ JOSHUA D
IPC: F24V30/00
Filed: 2002-05-20
Granted: 2008-09-04
Abstract: The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of an antipsychotic. In a method aspect of the present invention, an antipsychotic is delivered to a mammal through an inhalation route. The method comprises: a) Heating a composition, wherein the composition comprises at least 5 percent by weight of an antipsychotic, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering an antipsychotic through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of an antipsychotic; and, b) a device that forms an antipsychotic containing aerosol from the composition, for inhalation by the mammal.
Patent AU-2003291643-B2 (AU)
Title: Quinolinyl-pyrrolopyrazoles
Inventor: YINGLING JONATHAN MICHAEL
IPC: A61K31/4709
Filed: 2003-11-10
Granted: 2010-05-13
Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
Patent AU-2004260657-B2 (AU)
Title: Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
Inventor: KROLL JEREMY J
IPC: C07K16/12
Filed: 2004-07-15
Granted: 2012-06-07
Abstract: The present invention relates to <i>Lawsonia intracellularis</i> vaccines and methods for protecting against and diagnosing <i>L. intracellularis</i> infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of <i>L. intracellularis</i>, including both a novel isolate of <i>L. intracellularis</i> of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.